{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-1445"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-1445","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Deferasirox decreases age-associated iron accumulation in the aging F344BN rat heart","abstract":"It is thought that aging in rats and humans is associated with increases in iron accumulation and these increases in iron may be associated with increased cellular apoptosis. Here we examine the relationship between cardiac iron levels and cardiomyocyte apoptosis in aged F344BN rats which were treated with an oral iron chelator (Deferasirox; 100mg/kg body. weight/day) for 6 months. Compared with 6- month controls, the levels of cardiac iron, cardiac apoptosis, FLC and DMT-1 were higher in 33-month hearts. Deferasirox treatment for six months decreased cardiac iron and this was associated with decreases in the number of apoptotic cardiac myocytes. Age-associated increases in cardiac apoptosis were coupled with alterations in the amount of Bcl-2 and Bax. Deferasirox treatment increased Bcl-2 expression and decreased Bad and activated caspase-12 expression. Taken together, these data suggest deferasirox may be effective in diminishing age-associated iron accumulation and cardiac apoptosis in the aging F344BN rat model.","abstract_html":"It is thought that aging in rats and humans is associated with increases in iron accumulation and these increases in iron may be associated with increased cellular apoptosis. Here we examine the relationship between cardiac iron levels and cardiomyocyte apoptosis in aged F344BN rats which were treated with an oral iron chelator (Deferasirox; 100mg/kg body. weight/day) for 6 months. Compared with 6- month controls, the levels of cardiac iron, cardiac apoptosis, FLC and DMT-1 were higher in 33-month hearts. Deferasirox treatment for six months decreased cardiac iron and this was associated with decreases in the number of apoptotic cardiac myocytes. Age-associated increases in cardiac apoptosis were coupled with alterations in the amount of Bcl-2 and Bax. Deferasirox treatment increased Bcl-2 expression and decreased Bad and activated caspase-12 expression. Taken together, these data suggest deferasirox may be effective in diminishing age-associated iron accumulation and cardiac apoptosis in the aging F344BN rat model.","abstract_has_math":false,"creators":["Arvapalli, Ravi K."],"institution":null,"degree_name":"Biology","degree_level":"Thesis","degree_discipline":"College of Science","degree_department":null,"school":null,"contributors":["Eric R. Blough","David Mallory","Bin Wang"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:56:13Z","subjects":["Medical Cell Biology","Medical Sciences","Medicine and Health Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/445","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/445","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-1445","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Eric R. Blough","David Mallory","Bin Wang"]},{"key":"dc:creator","label":"Author","values":["Arvapalli, Ravi K."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2013-04-16T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2009-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["College of Science"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Biology"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medical Cell Biology","Medical Sciences","Medicine and Health Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/445"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["It is thought that aging in rats and humans is associated with increases in iron accumulation and these increases in iron may be associated with increased cellular apoptosis. Here we examine the relationship between cardiac iron levels and cardiomyocyte apoptosis in aged F344BN rats which were treated with an oral iron chelator (Deferasirox; 100mg/kg body. weight/day) for 6 months. Compared with 6- month controls, the levels of cardiac iron, cardiac apoptosis, FLC and DMT-1 were higher in 33-month hearts. Deferasirox treatment for six months decreased cardiac iron and this was associated with decreases in the number of apoptotic cardiac myocytes. Age-associated increases in cardiac apoptosis were coupled with alterations in the amount of Bcl-2 and Bax. Deferasirox treatment increased Bcl-2 expression and decreased Bad and activated caspase-12 expression. Taken together, these data suggest deferasirox may be effective in diminishing age-associated iron accumulation and cardiac apoptosis in the aging F344BN rat model."]},{"key":"dc:title","label":"Title","values":["Deferasirox decreases age-associated iron accumulation in the aging F344BN rat heart"]}]}],"canonical_facts":{"dc:contributor":["Eric R. Blough","David Mallory","Bin Wang"],"dc:creator":["Arvapalli, Ravi K."],"dc:date.available":["2013-04-16T07:00:00Z"],"dc:date.created":["2009-01-01T08:00:00Z"],"dc:description.abstract":["It is thought that aging in rats and humans is associated with increases in iron accumulation and these increases in iron may be associated with increased cellular apoptosis. Here we examine the relationship between cardiac iron levels and cardiomyocyte apoptosis in aged F344BN rats which were treated with an oral iron chelator (Deferasirox; 100mg/kg body. weight/day) for 6 months. Compared with 6- month controls, the levels of cardiac iron, cardiac apoptosis, FLC and DMT-1 were higher in 33-month hearts. Deferasirox treatment for six months decreased cardiac iron and this was associated with decreases in the number of apoptotic cardiac myocytes. Age-associated increases in cardiac apoptosis were coupled with alterations in the amount of Bcl-2 and Bax. Deferasirox treatment increased Bcl-2 expression and decreased Bad and activated caspase-12 expression. Taken together, these data suggest deferasirox may be effective in diminishing age-associated iron accumulation and cardiac apoptosis in the aging F344BN rat model."],"dc:identifier":["https://mds.marshall.edu/etd/445"],"dc:subject":["Medical Cell Biology","Medical Sciences","Medicine and Health Sciences"],"dc:title":["Deferasirox decreases age-associated iron accumulation in the aging F344BN rat heart"],"thesis:degree_discipline":["College of Science"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Biology"]},"updated_at":"2026-11-21T19:56:13Z"}